ArticleDrug delivery2018

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.

Ga Hee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.